SynopsisInactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin. The global Poliovirus Vaccine Inactivated market was valued at US$ 688.5 million in 2023 and is anticipa.....
SynopsisInactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin. The global Inactivated Poliovirus Vaccine market was valued at US$ 688.5 million in 2023 and is anticipa.....
SynopsisPneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F. The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at.....
SynopsisMenomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Th.....
SynopsisMeningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. The global Meningococcal Group B Vaccine market was valued at US$ 1107 million in 2023 and is anticipated to reach US$ 2034.2 million by 2030, witnessing a CAGR.....
SynopsisThe MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The global Measles, Mumps, and Rubella Virus Vaccine market was valued at US$ 388 million in 2023 and is anticipated to reach US$ 506.6 million by 2030, witnessing a CAGR .....
SynopsisJapanese Encephalitis vaccine info for parents, public, and healthcare professionals. The global Japanese Encephalitis Virus Vaccine market was valued at US$ 408.6 million in 2023 and is anticipated to reach US$ 572.2 million by 2030, witnessing a CAGR o.....
SynopsisLive, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global Cholera Vaccines Oral Live market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 143.7 millio.....
SynopsisLive, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global Oral Live Cholera Vaccines market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 143.7 millio.....
SynopsisThe drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones. The global Drugs of Ursodeoxycholic Acid market was valued at US$ 1645 milli.....
